ATF1 Recombinant Rabbit mAb (S-2883-124)
SKU: 66984636439

ATF1 Recombinant Rabbit mAb (S-2883-124)

Sale price$90.00 Regular price$100.00
Save 10%

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 9 - Jul 14

Promo Codes Available:

For Your Every Summer RSVP, with Code: SUMMER15

Description

ATF1 Recombinant Rabbit mAb (S-2883-124)Product Specification Host Rabbit Antigen ATF1 Synonyms Cyclic AMP dependent transcription factor ATF 1; cAMP dependent transcription factor ATF 1; Activating transcription factor 1; TCR ATF1; Atf1 Immunogen Synthetic Peptide Location Nucleus Accession P81269 Clone Number S 2883 124 Antibody Type Recombinant mAb Isotype IgG Application WB, ICC Reactivity Hu, Ms Positive Sample HeLa, 293T, A431, K562, RAW264. 7 Purification Protein A Concentration 0. 5

Product Specification


Host Rabbit
Antigen ATF1
Synonyms Cyclic AMP-dependent transcription factor ATF-1; cAMP-dependent transcription factor ATF-1; Activating transcription factor 1; TCR-ATF1; Atf1
Immunogen Synthetic Peptide
Location Nucleus
Accession P81269
Clone Number S-2883-124
Antibody Type Recombinant mAb
Isotype IgG
Application WB, ICC
Reactivity Hu, Ms
Positive Sample HeLa, 293T, A431, K562, RAW264.7
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms
ICC 1:500 Hu, Ms

Background

ATF1 (activating transcription factor 1) is a 271-amino-acid basic leucine-zipper (bZIP) protein that forms homo- or heterodimers with c-Jun, CREB or other bZIP partners to bind the consensus cAMP response element 5′-TGACGTCA-3′, thereby functioning as a stimulus-inducible transcriptional activator in cAMP, MAPK, calcium and stress-signaling cascades that govern proliferation, survival, melanocyte differentiation, synaptic plasticity and memory; it is subject to phosphorylation-driven control (notably by PKA at Ser63 and by p38/MSK1 at Ser63/121), acetylation and ubiquitination, is frequently fused to either EWSR1 or FUS in Ewing sarcoma and angiomatoid fibrous histiocytoma through t(12;22) or t(12;16) chromosomal translocations that convert it into an aberrant transcriptional activator, and its locus at 12q13 is co-amplified with CDK4 in a variety of sarcomas, underscoring its dual role as both a tightly regulated physiological transcription factor and an oncogenic driver.

Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
SKU: 66984636439

Discover Niche Categories That Outsell

Top-Converting Item to Boost Your Average Order

4.4 ★★★★★
Based on 352 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
B
Verified Purchase
Bri Hires
Dallas, US
★★★★★ 3
Slightly repetitive but I did love some things
Format: Kindle
I love this type of story. And omegaverse is one of my all time favorite genres. But there are a few things that pulled me out of my enjoyment while I was reading. It was repetitive at times as well as struggled with telling not showing. So we didn’t always feel like we were experiencing things with the main character. There were also some plot holes but they may still be answered in part 2. Now this isn’t to be said I didn’t enjoy parts of the story. I loved the almost instant love between Mila and Oliver. And how he started changing around her.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 15, 2024
K
Verified Purchase
Kimberly G
Massapequa, US
★★★★★ 5
delightful read
Format: Kindle
What a delightful read. The characters are awesome, the plot was so good, I loved it. I was intrigued and it kept me wanting more. Told in multiple pov, the book sucks you in and doesn’t let go. I cannot wait to read the next book.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 30, 2025
K
Verified Purchase
Kimberly B
Belleville, US
★★★★★ 4
not bad
Format: Kindle
I loved the plot of this book. The characters just didn’t have a lot of depth. The connections and “love” just weren’t communicated very well in the writing. The author didn’t write the sweet psycho trope very well at all either. Lachlan was just a mess of a character.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 17, 2023
C
Verified Purchase
Carmen Alicea
Chelsea, US
★★★★★ 5
A Beta Worth Rooting For
Format: Kindle
In Spare, Violet Fox flips the omegaverse on its head, giving us a Beta heroine determined to make her mark. Joining the Beta Trials to support her sick father, she's thrown into a pack that doesn't want her, especially the possessive Alphas. But here's the twist: their sweet Omega turns out to be her scent match. Cue the angst, forbidden tension, and a slow-burn romance that will make your heart ache in the best way. Violet Fox delivers an emotional, refreshing take on the genre, proving Betas aren't "spares." They're stars.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 10, 2025
C
Verified Purchase
C. Hunter
Massapequa, US
★★★★★ 5
Beta, Alpha, Omega oh my!
Format: Kindle
Omegas are precious and given to Alphas & their packs... but the Betas want in too. To this end, the Beta government is rolling out its trial of assigning a Beta to each Alpha-Omega pack. But forcing a Beta into a pack where they are not wanted will not end well... Of course, no one expected the Omega to fall for the assigned Beta. Great read and cliffhanger
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 15, 2025

recommand products